Stockscreener 앱 받기
10.37
3.29%
0.33
시장 영업 전:
10.33
-0.04
-0.39%
전일 마감가:
$10.04
열려 있는:
$10.2
하루 거래량:
795.90K
Relative Volume:
1.59
시가총액:
$936.68M
수익:
-
순이익/손실:
$-42.63M
주가수익비율:
-19.64
EPS:
-0.5281
순현금흐름:
$-39.43M
1주 성능:
-2.90%
1개월 성능:
+28.18%
6개월 성능:
+177.27%
1년 성능:
+245.67%
1일 변동 폭
$9.925
$10.71
1주일 범위
$9.76
$11.62
52주 변동 폭
$2.81
$11.62
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
10.37 | 906.87M | 0 | -42.63M | -39.43M | -0.5281 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
모두보기
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
DRTS Technical Analysis | Trend, Signals & Chart Patterns | ALPHA TAU MEDICAL LTD (NASDAQ:DRTS) - ChartMill
Alpha Tau Medical stock surges as interim brain tumor trial data sparks rally - MSN
DRTS Reiterated by HC Wainwright & Co. -- Price Target Maintained at $15 - GuruFocus
Alpha Tau Medical shares early Regain data: 2 complete responses in glioblastoma study - MSN
H.C. Wainwright reiterates Buy on Alpha Tau stock, $15 target - Investing.com India
H.C. Wainwright reiterates Buy on Alpha Tau stock, $15 target By Investing.com - Investing.com Australia
DRTSW Stock Price, Quote & Chart | ALPHA TAU MEDICAL LTD -27 (NASDAQ:DRTSW) - ChartMill
Piper Sandler raises Alpha Tau Medical stock price target on milestones - Investing.com Nigeria
Alpha Tau Medical Releases Q1 2026 Financial Results - AlphaStreet
Alpha Tau price target raised to $8 from $5 at Piper Sandler - TipRanks
Japan Approves Alpha DaRT, a Breakthrough in Cancer Radiation Therapy - BriefGlance
Piper Sandler raises Alpha Tau Medical stock price target on milestones By Investing.com - Investing.com South Africa
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update - Sahm
Alpha Tau Medical stock (IL0011833879): Q1 trial progress and investor conferences lift focus - AD HOC NEWS
Alpha Tau Medical earnings missed by $0.14, revenue fell short of estimates - Investing.com Australia
Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay - TipRanks
Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study - TipRanks
Alpha Tau Medical (NASDAQ: DRTS) sets 2026 shareholder vote on pay, board and auditors - Stock Titan
Alpha Tau Medical Ltd options imply 16.0% move in share price post-earnings - TipRanks
Alpha Tau (NASDAQ: DRTS) posts larger Q1 2026 loss while cancer trials reach key milestones - Stock Titan
Press Release: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update - Moomoo
Alpha Tau to Participate in May Investor Conferences - GlobeNewswire
DRTS Q1'26 Earnings: revenue estimate is 49.75K USD - TradingView
NASDAQ New 52-Week Highs And Lows - Moomoo
Alpha Tau Medical (DRTS) price target increased by 13.16% to 10.96 - MSN
symbol__ Stock Quote Price and Forecast - CNN
Number of shareholders of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
TradingKey - TradingKey
Ladenburg Thalmann Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $14 - Moomoo
H.C. Wainwright raises Alpha Tau Medical stock price target to $15 on trial data - Investing.com UK
H.C. Wainwright raises Alpha Tau Medical stock price target to $15 on trial data By Investing.com - Investing.com South Africa
Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally - Sahm
Alpha Tau Says Complete Response in 2 Brain Cancer Patients Observed in Interim Trial of Radiation Treatment - Moomoo
Alpha Tau Medical Shares Gain on Positive Results From Brain-Cancer Treatment Trial - Moomoo
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Alpha Tau Medical (NASDAQ:DRTS) Sets New 52-Week HighTime to Buy? - MarketBeat
Alpha Tau Wiped Out Visible Tumors in Two of Three Brain Cancer Patients in Its First U.S. Trial - TipRanks
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study - MarketBeat
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT - TipRanks
Alpha Tau (DRTS) shows early Alpha DaRT results in recurrent GBM trial - Stock Titan
Alpha Tau reports interim results from brain cancer trial By Investing.com - Investing.com Australia
Alpha Tau Medical stock surges on brain cancer trial results By Investing.com - Investing.com Nigeria
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
0.12%
자본화:
|
볼륨(24시간):